Follow the people · Insider
Marshall Fordyce
Marshall Fordyce files insider transactions with the SEC as a president and ceo of Vera Therapeutics (VERA). We hold 9 disclosed purchases and sales filed since 17 May 2021, 6 of them in the last 90 days.
- Files forVERA
- Disclosed buys and sells9 in all, 6 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 May 2021 — 2 September 2026President and CEO · Vera Therapeutics (VERA)224 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,500 shares of Vera TherapeuticsSEC Form 44 September 2026Class A Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 18,500 shares of Vera TherapeuticsSEC Form 44 September 2026Class A Common Stock · traded 2 September 2026 · filed 4 September 2026
- exercised options over 18,500 shares of Vera Therapeutics (a derivative holding)SEC Form 44 September 2026Stock Option (Right to Buy) · traded 2 September 2026 · filed 4 September 2026
- exercised options over 18,500 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 12 May 2026 · filed 12 August 2026
- ▼ sold on the open market 14,219 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 12 May 2026 · filed 12 August 2026
- ▼ sold on the open market 4,281 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 12 May 2026 · filed 12 August 2026
- exercised options over 18,500 shares of Vera Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option (Right to Buy) · traded 12 May 2026 · filed 12 August 2026
- exercised options over 18,500 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 23 June 2026 · filed 12 August 2026
- ▼ sold on the open market 18,412 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 23 June 2026 · filed 12 August 2026
- ▼ sold on the open market 88 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 23 June 2026 · filed 12 August 2026
- exercised options over 18,500 shares of Vera Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option (Right to Buy) · traded 23 June 2026 · filed 12 August 2026
- exercised options over 46,250 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 7 July 2026 · filed 12 August 2026
- ▼ sold on the open market 1,000 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 7 July 2026 · filed 12 August 2026
- ▼ sold on the open market 32,550 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 7 July 2026 · filed 12 August 2026
- ▼ sold on the open market 10,500 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 7 July 2026 · filed 12 August 2026
- ▼ sold on the open market 2,200 shares of Vera TherapeuticsSEC Form 412 August 2026Class A Common Stock · traded 7 July 2026 · filed 12 August 2026
- exercised options over 46,250 shares of Vera Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option (Right to Buy) · traded 7 July 2026 · filed 12 August 2026
- ▼ sold on the open market 1,000 shares of Vera TherapeuticsSEC Form 49 July 2026Class A Common Stock · traded 7 July 2026 · filed 9 July 2026
- ▼ sold on the open market 32,550 shares of Vera TherapeuticsSEC Form 49 July 2026Class A Common Stock · traded 7 July 2026 · filed 9 July 2026
- ▼ sold on the open market 10,500 shares of Vera TherapeuticsSEC Form 49 July 2026Class A Common Stock · traded 7 July 2026 · filed 9 July 2026
- ▼ sold on the open market 2,200 shares of Vera TherapeuticsSEC Form 49 July 2026Class A Common Stock · traded 7 July 2026 · filed 9 July 2026
- ▼ sold on the open market 18,412 shares of Vera TherapeuticsSEC Form 424 June 2026Class A Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▼ sold on the open market 88 shares of Vera TherapeuticsSEC Form 424 June 2026Class A Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▼ sold on the open market 14,219 shares of Vera TherapeuticsSEC Form 413 May 2026Class A Common Stock · traded 12 May 2026 · filed 13 May 2026
- ▼ sold on the open market 4,281 shares of Vera TherapeuticsSEC Form 413 May 2026Class A Common Stock · traded 12 May 2026 · filed 13 May 2026
- ▼ sold on the open market 14,130 shares of Vera TherapeuticsSEC Form 415 April 2026Class A Common Stock · traded 14 April 2026 · filed 15 April 2026
- ▼ sold on the open market 7,921 shares of Vera TherapeuticsSEC Form 415 April 2026Class A Common Stock · traded 14 April 2026 · filed 15 April 2026
- ▼ sold on the open market 900 shares of Vera TherapeuticsSEC Form 415 April 2026Class A Common Stock · traded 14 April 2026 · filed 15 April 2026
- ▼ sold on the open market 16,925 shares of Vera TherapeuticsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 16,925 shares of Vera TherapeuticsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- was granted 68,800 shares of Vera TherapeuticsSEC Form 46 February 2026Class A Common Stock · traded 4 February 2026 · filed 6 February 2026
- was granted 137,500 shares of Vera Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 137,500 shares of Vera Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 68,800 shares of Vera TherapeuticsSEC Form 46 February 2026Class A Common Stock · traded 4 February 2026 · filed 6 February 2026
- ▼ sold on the open market 10,613 shares of Vera TherapeuticsSEC Form 427 February 2025Class A Common Stock · traded 21 February 2025 · filed 27 February 2025
- ▼ sold on the open market 7,975 shares of Vera TherapeuticsSEC Form 427 February 2025Class A Common Stock · traded 26 February 2025 · filed 27 February 2025
- ▼ sold on the open market 1,100 shares of Vera TherapeuticsSEC Form 427 February 2025Class A Common Stock · traded 26 February 2025 · filed 27 February 2025
- was granted 161,500 shares of Vera Therapeutics (a derivative holding)SEC Form 420 February 2025Stock Option (right to buy) · traded 18 February 2025 · filed 20 February 2025
- was granted 80,750 shares of Vera TherapeuticsSEC Form 420 February 2025Class A Common Stock · traded 18 February 2025 · filed 20 February 2025
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 410 January 2025Stock Option (Right to Buy) · traded 8 January 2025 · filed 10 January 2025
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 410 January 2025Stock Option (Right to Buy) · traded 8 January 2025 · filed 10 January 2025
- exercised options over 9,975 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- ▼ sold on the open market 9,975 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- exercised options over 5,650 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- ▼ sold on the open market 5,650 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 410 January 2025Class A Common Stock · traded 8 January 2025 · filed 10 January 2025
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 420 December 2024Stock Option (Right to Buy) · traded 18 December 2024 · filed 20 December 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 420 December 2024Stock Option (Right to Buy) · traded 18 December 2024 · filed 20 December 2024
- exercised options over 57,661 shares of Vera Therapeutics (a derivative holding)SEC Form 420 December 2024Stock Option (Right to Buy) · traded 19 December 2024 · filed 20 December 2024
- exercised options over 3,772 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 3,772 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- exercised options over 2,195 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 2,195 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- exercised options over 5,023 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 5,023 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- exercised options over 4,635 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 4,635 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 18 December 2024 · filed 20 December 2024
- exercised options over 57,661 shares of Vera TherapeuticsSEC Form 420 December 2024Class A Common Stock · traded 19 December 2024 · filed 20 December 2024
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 413 December 2024Stock Option (Right to Buy) · traded 11 December 2024 · filed 13 December 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 413 December 2024Stock Option (Right to Buy) · traded 11 December 2024 · filed 13 December 2024
- exercised options over 14,925 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 14,925 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- exercised options over 700 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 700 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- exercised options over 1,775 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 1,775 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- exercised options over 100 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 100 shares of Vera TherapeuticsSEC Form 413 December 2024Class A Common Stock · traded 11 December 2024 · filed 13 December 2024
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 427 November 2024Stock Option (Right to Buy) · traded 25 November 2024 · filed 27 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 427 November 2024Stock Option (Right to Buy) · traded 25 November 2024 · filed 27 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 427 November 2024Stock Option (Right to Buy) · traded 25 November 2024 · filed 27 November 2024
- exercised options over 6,579 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 6,579 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- exercised options over 7,665 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 7,665 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- exercised options over 1,381 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 1,381 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 427 November 2024Class A Common Stock · traded 25 November 2024 · filed 27 November 2024
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 7,500 shares of Vera Therapeutics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 13 November 2024 · filed 15 November 2024
- exercised options over 12,218 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 12,218 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 3,307 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 3,307 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 100 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 100 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,565 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 1,565 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 310 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 310 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 1,875 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 7,500 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- ▼ sold on the open market 7,500 shares of Vera TherapeuticsSEC Form 415 November 2024Class A Common Stock · traded 13 November 2024 · filed 15 November 2024
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 425 October 2024Stock Option (Right to Buy) · traded 23 October 2024 · filed 25 October 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 425 October 2024Stock Option (Right to Buy) · traded 23 October 2024 · filed 25 October 2024
- exercised options over 1,875 shares of Vera Therapeutics (a derivative holding)SEC Form 425 October 2024Stock Option (Right to Buy) · traded 23 October 2024 · filed 25 October 2024
- exercised options over 12,715 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- ▼ sold on the open market 12,715 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- exercised options over 2,310 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- ▼ sold on the open market 2,310 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- exercised options over 600 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- ▼ sold on the open market 600 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- exercised options over 3,750 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- ▼ sold on the open market 3,750 shares of Vera TherapeuticsSEC Form 425 October 2024Class A Common Stock · traded 23 October 2024 · filed 25 October 2024
- exercised options over 15,625 shares of Vera Therapeutics (a derivative holding)SEC Form 411 October 2024Stock Option (Right to Buy) · traded 9 October 2024 · filed 11 October 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.